Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03048318
Other study ID # ILBS-ArterialFlush-001
Secondary ID
Status Completed
Phase Phase 4
First received January 31, 2017
Last updated June 28, 2017
Start date October 1, 2015
Est. completion date April 30, 2017

Study information

Verified date January 2017
Source Institute of Liver and Biliary Sciences, India
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Arterial flushing is a standard recommendation in deceased donor liver transplantation but not in living donor liver transplantation due to the risk of arterial intimal injury and short cold ischaemia time. There is recent evidence on benefit of retrograde arterial perfusion using hepatic venous occlusion and its benefits on post transplant cholestasis. However there is no data on antegrade arterial flushing.


Description:

Biliary reconstruction has been labeled the "Achilles heel" of liver transplantation and is a common cause of postoperative morbidity and also mortality .Living donor liver transplantation (LDLT) has a higher incidence of biliary complications of up to 30% which is higher than Deceased Donor Liver Transplantation and does not seem to improve significantly with experience.The virtually unchanged incidence of biliary strictures suggests that they are not simply "technical" in origin, but probably represent a mucosa ischemic injury inherent in the transplantation procedure. The blood supply of the bile duct is mainly from the arterial system and skeletonisation of the duct during dissection impairs the blood supply rendering it ischemic.

Various donor maneuvers for better flushing and preserving peribiliary vascular plexus and biliary mucosa have been studied to decrease biliary complications. LDLT have advantages of haemodynamic stable donor and short cold ischemia but also has disadvantages of small graft size, small ducts, complicated reconstruction and absence of arterial flush. Conventional portal flush in animal livers could not remove warm blood from the arterial system and grafts without retrograde arterial flush had higher post operative bilirubin.With further studies in Living Donor Liver Transplant, it was concluded that retrograde flushing may ameliorate post operative cholestasis. There has not been data published on antegrade arterial flushing and its effect on biliary complications in Living Donor Liver Transplant. This study aims to compare back table graft arterial and portal flushing with portal flushing alone and evaluate biliary and arterial complications.

Arterial flushing has been made part of standard protocol at our institute and its safety established. There are centers which routinely perform back table arterial flush.


Recruitment information / eligibility

Status Completed
Enrollment 85
Est. completion date April 30, 2017
Est. primary completion date April 30, 2017
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- All patients undergoing living donor liver transplant for decompensated chronic liver disease with right lobe grafts only

Exclusion Criteria:

- Donor artery size less than 2 mm

- More than one donor artery

- GRWR <0.8

- ABO incompatible grafts

- Refusal to participate in the study

- Emergency transplants

Study Design


Intervention

Procedure:
Arterial Flushing

Portal Flushing


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Institute of Liver and Biliary Sciences, India

Outcome

Type Measure Description Time frame Safety issue
Primary Effects on biliary complications Occurence of biliary complication Three months
Secondary Hospital stay Occurrence of complications 1 month
Secondary Morbidity 1 month
Secondary Effect on graft function 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT01829139 - Efficacy of Choleretics in Acalculous Gallbladder in Situ After Endoscopic Removal of Biliary Stones N/A